Security key
00847X104
AGIOS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (the "Shares") (AGIO)
CUSIP: 00847X104
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Stock, par value $0.001 per share (the "Shares")
- Total 13F shares
- 65,869,834
- Total 13F value
- $2,304,359,620
- Share change
- -1,619,894
- Put/Call ratio
- 126%
- SEC-reported price per share
- $35.00
- Number of holders
- 206
- Value change
- -$101,763,130
- Number of buys
- 112
- Number of sells
- 91
- Shares outstanding
- 59,771,717
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
206
Top holders
10
AGIO full security history
Ownership snapshot
Full 13F holder table
AGIOS PHARMACEUTICALS, INC. SEC filings
AGIOS PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership
Top 5
WELLINGTON MANAGEMENT GROUP LLP
13%
VANGUARD GROUP INC
9.6%
FMR LLC
9.4%
BlackRock Finance, Inc.
8.4%
Bellevue Group AG
6.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
13%
|
$420,720,000
7,866,877 shares
|
— | 30 Jun 2020 |
| VANGUARD GROUP INC |
13F
Company
|
9.6%
|
$307,237,000
5,744,910 shares
|
— | 30 Jun 2020 |
| FMR LLC |
13F
Company
|
9.4%
|
$300,361,000
5,616,327 shares
|
— | 30 Jun 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
8.4%
|
$267,764,000
5,006,831 shares
|
— | 30 Jun 2020 |
| Bellevue Group AG |
13F
Company
|
6.7%
|
$215,181,000
4,023,573 shares
|
— | 30 Jun 2020 |
| Capital International Investors |
13F
Company
|
6.4%
|
$206,156,000
3,854,832 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
206
Shares
65,869,834
Rows available
206
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
205
Q3 2020 holders
206
Holder diff
1
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|